---
figid: PMC6571149__nihms-890859-f0008
figtitle: Model of Bcl3 activation
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Escherichia coli
- Oryctolagus cuniculus
- Escherichia coli O55
- Homo sapiens
- Oryza sativa
- vectors
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC6571149
filename: nihms-890859-f0008.jpg
figlink: /pmc/articles/PMC6571149/figure/F7/
number: F7
caption: In resting cells, Bcl3 undergoes continuous degradation mediated by the GSK3β
  phosphorylation possibly at Ser394 and Ser398. Upon LPS stimulation, Akt undergoes
  activation through in the PI3K signaling pathway and stabilizes Bcl3 through two
  mechanisms; inactivating GSK3β through direct phosphorylation and inducing nuclear
  translocation by phosphorylation of Bcl3 at Ser33. Akt might be directly involved
  in IKK1 phosphorylation. IKK2 is phosphorylated by canonical NF-kB activation pathway.
  IKK in turn leads to Bcl3 phosphorylation at Ser446 and other residues. In addition,
  Erk2 also gets activated in the MAPK/ERK pathways and phosphorylates Bcl3 at Ser114.
  All three phosphorylation events increase Bcl3’s transcriptional potential with
  NF-κB p52.
papertitle: Bcl3 phosphorylation by Akt, Erk2 and IKK is required for its transcriptional
  activity.
reftext: Vivien Ya-Fan Wang, et al. Mol Cell. 2017 Aug 3;67(3):484-497.e5.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9591691
figid_alias: PMC6571149__F7
figtype: Figure
redirect_from: /figures/PMC6571149__F7
ndex: eed66d30-dedd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6571149__nihms-890859-f0008.html
  '@type': Dataset
  description: In resting cells, Bcl3 undergoes continuous degradation mediated by
    the GSK3β phosphorylation possibly at Ser394 and Ser398. Upon LPS stimulation,
    Akt undergoes activation through in the PI3K signaling pathway and stabilizes
    Bcl3 through two mechanisms; inactivating GSK3β through direct phosphorylation
    and inducing nuclear translocation by phosphorylation of Bcl3 at Ser33. Akt might
    be directly involved in IKK1 phosphorylation. IKK2 is phosphorylated by canonical
    NF-kB activation pathway. IKK in turn leads to Bcl3 phosphorylation at Ser446
    and other residues. In addition, Erk2 also gets activated in the MAPK/ERK pathways
    and phosphorylates Bcl3 at Ser114. All three phosphorylation events increase Bcl3’s
    transcriptional potential with NF-κB p52.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - GSK3B
  - BCL3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - EPHB2
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - FKBP4
  - GTF2H4
  - NFKB2
  - PMPCB
  - PSIP1
  - H3P42
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - SOD1
  - NFKB1
  - RELA
  - RELB
  - REL
  - TBL1XR1
  - Akt1
  - Pik3r1
  - Gsk3b
  - Bcl3
  - Ephb2
  - Mapk1
  - S100a14
  - Gtf2h4
  - Nfkb2
  - Igbp1
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Tbl1xr1
  - Pik3cg
  - Ephb1
  - Rela
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - sgg
  - Axn
  - gskt
  - MKP-4
  - p38b
  - rl
  - Erk7
  - p38a
  - IKKepsilon
  - key
  - IKKbeta
  - mrn
  - Hrb27C
  - betaTub60D
  - Rpt5
  - DCTN2-p50
  - Dif
  - dl
  - Rel
  - Cancer
---
